The content on this site is intended for healthcare professionals only
Dr Arafat speaks with ecancertv at ESMO 2016 about TRAIL, an apoptotic receptor - ligand pairing with modulated expression in cancer cells, which he believes could restore cell death to tumours.
He considers delivery systems by which TRAIL might be introduced, and its synergistic potential with chemotherapy or radiotherapy.
Digital pathology superior to manual SP263 PD-L1 TC scoring for stage II-IIIA high PD-L1 expression NSCLC
Made to measure: Choosing the optimal regimen in transplant-eligible NDMM
Revolutionising myeloma treatment through immune profiling
ESMO 2024: Optimising the personalisation of prostate cancer treatment
Multiple myeloma in a resource constrained setting
First-line NALIRIFOX shows improvement in OS and PFS in metastatic pancreatic cancer
Choosing Wisely in pathology
Choosing Wisely in radiology Tanzania
Overview of the management of HER2-low breast cancer patients
